Four years treatment with Zoledronic Acid is superior to two years in protection against progressive bone disease in Multiple Myeloma

Gundesen MT; Fredrik H.  Schjesvold; Annette Juul Vangsted; Carsten Helleberg; Einar Haukas; Trine Silkjaer; Elena Manuela Teodorescu; Bo Amdi Jensen; Tobias  Slordahl; Jon Thor Asmussen; Hareth Nahi; Niels Abildgaard; Thomas Lund

Four years treatment with Zoledronic Acid is superior to two years in protection against progressive bone disease in Multiple Myeloma

Gundesen MT^*, Fredrik H. Schjesvold, Annette Juul Vangsted, Carsten Helleberg, Einar Haukas, Trine Silkjaer, Elena Manuela Teodorescu, Bo Amdi Jensen, Tobias Slordahl, Jon Thor Asmussen, Hareth Nahi, Niels Abildgaard, Thomas Lund

^*Kontaktforfatter

Publikation: Konferencebidrag uden forlag/tidsskrift › Konferenceabstrakt til konference › Forskning › peer review

Originalsprog	Engelsk
Publikationsdato	27. sep. 2023
Status	Udgivet - 27. sep. 2023
Begivenhed	20th International Myeloma Society Annual Meeting and Exposition - Athen, Grækenland Varighed: 27. sep. 2023 → 30. sep. 2023

Konference

Konference	20th International Myeloma Society Annual Meeting and Exposition
Land/Område	Grækenland
By	Athen
Periode	27/09/2023 → 30/09/2023

Dokumenter og links

https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S215226502301577X?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS215226502301577X%3Fshowall%3Dtrue&referrer=

Citationsformater

MT, G., Schjesvold, F. H., Vangsted, A. J., Helleberg, C., Haukas, E., Silkjaer, T., Teodorescu, E. M., Jensen, B. A., Slordahl, T., Asmussen, J. T., Nahi, H., Abildgaard, N., & Lund, T. (2023). Four years treatment with Zoledronic Acid is superior to two years in protection against progressive bone disease in Multiple Myeloma. Abstract fra 20th International Myeloma Society Annual Meeting and Exposition , Athen, Grækenland. https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S215226502301577X?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS215226502301577X%3Fshowall%3Dtrue&referrer=

@conference{aa2c183445d84b868f52d6c2ddb9336a,

title = "Four years treatment with Zoledronic Acid is superior to two years in protection against progressive bone disease in Multiple Myeloma",

author = "Gundesen MT and Schjesvold, {Fredrik H.} and Vangsted, {Annette Juul} and Carsten Helleberg and Einar Haukas and Trine Silkjaer and Teodorescu, {Elena Manuela} and Jensen, {Bo Amdi} and Tobias Slordahl and Asmussen, {Jon Thor} and Hareth Nahi and Niels Abildgaard and Thomas Lund",

year = "2023",

month = sep,

day = "27",

language = "English",

note = "20th International Myeloma Society Annual Meeting and Exposition ; Conference date: 27-09-2023 Through 30-09-2023",

}

MT, G, Schjesvold, FH, Vangsted, AJ, Helleberg, C, Haukas, E, Silkjaer, T, Teodorescu, EM, Jensen, BA, Slordahl, T, Asmussen, JT, Nahi, H, Abildgaard, N & Lund, T 2023, 'Four years treatment with Zoledronic Acid is superior to two years in protection against progressive bone disease in Multiple Myeloma', 20th International Myeloma Society Annual Meeting and Exposition , Athen, Grækenland, 27/09/2023 - 30/09/2023. <https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S215226502301577X?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS215226502301577X%3Fshowall%3Dtrue&referrer=>

Four years treatment with Zoledronic Acid is superior to two years in protection against progressive bone disease in Multiple Myeloma. / MT, Gundesen; Schjesvold, Fredrik H. ; Vangsted, Annette Juul et al.
2023. Abstract fra 20th International Myeloma Society Annual Meeting and Exposition , Athen, Grækenland.

Publikation: Konferencebidrag uden forlag/tidsskrift › Konferenceabstrakt til konference › Forskning › peer review

TY - ABST

T1 - Four years treatment with Zoledronic Acid is superior to two years in protection against progressive bone disease in Multiple Myeloma

AU - MT, Gundesen

AU - Schjesvold, Fredrik H.

AU - Vangsted, Annette Juul

AU - Helleberg, Carsten

AU - Haukas, Einar

AU - Silkjaer, Trine

AU - Teodorescu, Elena Manuela

AU - Jensen, Bo Amdi

AU - Slordahl, Tobias

AU - Asmussen, Jon Thor

AU - Nahi, Hareth

AU - Abildgaard, Niels

AU - Lund, Thomas

PY - 2023/9/27

Y1 - 2023/9/27

M3 - Conference abstract for conference

T2 - 20th International Myeloma Society Annual Meeting and Exposition

Y2 - 27 September 2023 through 30 September 2023

ER -